Literature DB >> 13814376

Epidemiology of poliomyelitis in Israel, 1952-59, with evaluation of Salk vaccination during a three-year period.

A M DAVIES, K MARBERG, N GOLDBLUM, S LEVINE, P YEKUTIEL.   

Abstract

The epidemic of poliomyelitis which occurred in Israel in 1958 among a population a large proportion of which had received inactivated Salk-type vaccine aroused great interest. This was the first time a vaccinated infant population had been exposed to a severe epidemic and thus afforded the first opportunity to determine whether or not vaccination afforded a high degree of protection in this age-group. The authors report on the observations made.While the vaccine conferred some protection, this was not of so high a degree as had been expected from experience elsewhere in older children. This partial failure may be explained in part by the use in the earlier vaccination campaigns of vaccines of lower potency than is now current and perhaps by the fact that many vaccinations were performed intradermally.No very exact measure of the protection conferred can be given. For some groups the figures are too small for statistical validity; for others, it is not possible to distinguish between the effect of vaccine and that of age, the latter possibly being the more important factor.

Entities:  

Keywords:  POLIOMYELITIS/epidemiology

Mesh:

Substances:

Year:  1960        PMID: 13814376      PMCID: PMC2555311     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  22 in total

1.  [The clinical picture of poliomyelitis after the inoculation program].

Authors:  Y ROTEM
Journal:  Harefuah       Date:  1959-02-15

2.  Quarantine measures in poliomyelitis.

Authors:  A P GOFFE; E M PARFITT
Journal:  Lancet       Date:  1955-06-04       Impact factor: 79.321

3.  The virus of St. Louis encephalitis in chickens.

Authors:  W D SUDIA; R W CHAMBERLAIN
Journal:  Am J Hyg       Date:  1959-09

4.  Effect of leucine-vasopressin (phenylalanine-oxytocin) on renal excretion of Na and K in hydrated rats and dogs.

Authors:  N A THORN; B MILEWSKI
Journal:  Proc Soc Exp Biol Med       Date:  1959-02

5.  Note on antibodies to poliomyelitis viruses in the sera of residents of Eastern Saudi Arabia.

Authors:  S PAYZIN; E S MURRAY
Journal:  Am J Trop Med Hyg       Date:  1957-07       Impact factor: 2.345

6.  How many injections of poliomyelitis vaccine for effective and durable immunity.

Authors:  J E SALK
Journal:  J Am Med Assoc       Date:  1958-05-03

7.  Intermittent positive pressure respiration in infants with poliomyelitis.

Authors:  Y ROTEM; E CHIGIER; L RANNON
Journal:  Acta Paediatr       Date:  1958-07       Impact factor: 2.299

8.  Isolation and identification of strains of poliomyelitis in tissue cultures.

Authors:  H BERNKOPF
Journal:  Harefuah       Date:  1954-11-15

9.  Polio vaccination in Denmark in April-June 1955. I. The production of formalinized poliovaccine and preliminary results.

Authors:  H VON MAGNUS; P VON MAGNUS; I PETERSEN; A GODTFREDSEN; M RONKJAER
Journal:  Dan Med Bull       Date:  1955-12

10.  Poliomyelitis outbreak in Israel, 1950-1.

Authors:  P YEKUTIEL; E L LEVINGER; H V MUHSAM; M P YEKUTIEL
Journal:  Bull World Health Organ       Date:  1955       Impact factor: 9.408

View more
  4 in total

1.  The epidemiology in infectious hepatitis in Israel.

Authors:  A M Davies; A Suchowolski
Journal:  J Hyg (Lond)       Date:  1961-03

2.  Population genetics applied to live poliovirus vaccine.

Authors:  J L MELNICK
Journal:  Am J Public Health Nations Health       Date:  1962-03

3.  The problem of paralytic poliomyelitis in the urban and rural population around Lucknow, India.

Authors:  U C Chaturvedi; A Mathur; U K Singh; M R Kushwaha; R M Mehrotra; A K Kapoor; S Rai; R G Gurha
Journal:  J Hyg (Lond)       Date:  1978-10

Review 4.  Poliomyelitis control in Israel, the West Bank and Gaza Strip: changing strategies with the goal of eradication in an endemic area.

Authors:  N Goldblum; C B Gerichter; T H Tulchinsky; J L Melnick
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.